NanoString Technologies ROE 2011-2018 | NSTG

Current and historical return on equity (ROE) values for NanoString Technologies (NSTG) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. NanoString Technologies ROE for the three months ending December 31, 2018 was -252.59%.
NanoString Technologies ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-12-31 $-0.08B $0.04B -250.41%
2018-09-30 $-0.07B $0.05B -206.35%
2018-06-30 $-0.06B $0.01B -201.68%
2018-03-31 $-0.04B $0.03B -108.64%
2017-12-31 $-0.04B $0.04B -131.34%
2017-09-30 $-0.05B $0.05B -177.36%
2017-06-30 $-0.05B $0.05B -340.74%
2017-03-31 $-0.05B $-0.00B -10400.00%
2016-12-31 $-0.05B $0.01B -1371.43%
2016-09-30 $-0.05B $-0.01B -818.18%
2016-06-30 $-0.04B $0.00B -314.29%
2016-03-31 $-0.05B $0.01B -200.00%
2015-12-31 $-0.05B $0.02B -159.29%
2015-09-30 $-0.05B $0.03B -139.13%
2015-06-30 $-0.05B $0.03B -122.16%
2015-03-31 $-0.05B $0.03B -106.53%
2014-12-31 $-0.05B $0.05B -79.67%
2014-09-30 $-0.05B $0.06B -79.31%
2014-06-30 $-0.04B $0.07B -77.78%
2014-03-31 $-0.04B $0.08B -97.30%
2013-12-31 $-0.04B $0.03B -194.44%
2013-09-30 $-0.03B $0.04B -250.98%
2013-06-30 $-0.03B $-0.00B -1127.27%
2013-03-31 $-0.03B $0.00B -861.54%
2012-12-31 $-0.02B $0.01B -920.00%
2012-09-30 $-0.02B $0.00B -566.67%
2012-06-30 $-0.01B $0.00B -333.33%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.781B $0.107B
NanoString Technologies, Inc. is engaged in the development, manufacture and sale of life science tools. It provides nCounter Analysis System which supports research and development of clinical applications from basic discovery to the development of future molecular diagnostic tests on a single platform. The company also offers nSolver Analysis software, gene expression panels, miRNA expression assay kits, cancer copy number variation panels, nCounter leukemia fusion gene expression assay kits and human karyotype panels, custom CodeSets and master kits that are ancillary reagents, cartridges, tips and reagent plates to setup and process samples in its instruments. It markets its systems and related consumables to researchers in academic, government and biopharmaceutical laboratories primarily in North America, Europe, the Middle East and the Asia Pacific. NanoString Technologies, Inc. is headquartered in Seattle, Washington.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $133.667B 26.06
Medtronic (MDT) Ireland $114.132B 16.69
Stryker (SYK) United States $69.756B 24.90
Boston Scientific (BSX) United States $49.905B 24.25
Baxter (BAX) United States $39.019B 25.03
Zimmer Biomet Holdings (ZBH) United States $25.114B 16.07
Smith & Nephew SNATS (SNN) United Kingdom $16.786B 0.00
Canopy Growth (CGC) Canada $16.315B 0.00
ResMed (RMD) United States $14.544B 27.58
Aurora Cannabis (ACB) Canada $9.179B 64.71
Bio-Rad Laboratories (BIO) United States $8.795B 50.45
Perrigo (PRGO) Ireland $6.734B 10.92
Hill-Rom Holdings (HRC) United States $6.397B 19.79
GW Pharmaceuticals (GWPH) United Kingdom $4.994B 0.00
Insulet (PODD) United States $4.964B 1664.20
ICU Medical (ICUI) United States $4.636B 28.71
Haemonetics (HAE) United States $4.354B 38.62
Hutchison China MediTech (HCM) China $3.962B 0.00
Agios Pharmaceuticals (AGIO) United States $3.443B 0.00
Neogen (NEOG) United States $3.004B 48.85
NuVasive (NUVA) United States $2.967B 25.77
Quidel (QDEL) United States $2.487B 22.25
National Vision Holdings (EYE) United States $2.276B 44.77
Aphria (APHA) $1.957B 0.00
HEXO (HEXO) $1.474B 0.00
Phibro Animal Health (PAHC) United States $1.338B 19.24
VAREX IMAGING (VREX) United States $1.234B 24.16
Cardiovascular Systems (CSII) United States $1.212B 870.25
AtriCure (ATRC) United States $1.076B 0.00
Lantheus Holdings (LNTH) United States $0.957B 25.86
Omeros (OMER) United States $0.929B 0.00
PetIQ (PETQ) United States $0.865B 24.76
Cerus (CERS) United States $0.831B 0.00
MacroGenics (MGNX) United States $0.820B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.725B 24.66
TG Therapeutics (TGTX) United States $0.717B 0.00
Evolus (EOLS) United States $0.708B 0.00
OraSure Technologies (OSUR) United States $0.589B 25.68
Surmodics (SRDX) United States $0.584B 84.94
LeMaitre Vascular (LMAT) United States $0.555B 26.37
Meridian Bioscience (VIVO) United States $0.538B 16.02
Quanterix (QTRX) United States $0.515B 0.00
Insys Therapeutics (INSY) United States $0.332B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.329B 0.00
Utah Medical Products (UTMD) United States $0.326B 21.19
BioLife Solutions (BLFS) United States $0.302B 124.61
Vapotherm (VAPO) United States $0.287B 0.00
Rockwell Medical (RMTI) United States $0.270B 0.00
Cytosorbents (CTSO) United States $0.228B 0.00
Owens & Minor (OMI) United States $0.213B 2.91
Zynex (ZYXI) United States $0.172B 18.38
Bovie Medical (APYX) United States $0.140B 0.00
Chimerix (CMRX) United States $0.138B 0.00
Fonar (FONR) United States $0.128B 6.85
Chembio Diagnostics (CEMI) United States $0.122B 0.00
Surface Oncology (SURF) United States $0.114B 0.00
United-Guardian (UG) United States $0.089B 20.32
Female Health (VERU) United States $0.088B 0.00
InfuSystems Holdings (INFU) United States $0.085B 0.00
Neurotrope (NTRP) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.069B 0.00
Trinity Biotech (TRIB) Ireland $0.067B 19.86
GUARDION HEALTH (GHSI) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.045B 0.00
Senestech (SNES) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.024B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.007B 13.00